Search Results - "Hayase, Suguru"

Refine Results
  1. 1
  2. 2
  3. 3

    Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer by Chida, Shun, Okayama, Hirokazu, Noda, Masaru, Saito, Katsuharu, Nakajima, Takahiro, Aoto, Keita, Hayase, Suguru, Momma, Tomoyuki, Ohki, Shinji, Kono, Koji, Takenoshita, Seiichi

    Published in Carcinogenesis (New York) (01-09-2016)
    “…To develop prognostic biomarkers that can discriminate stage II-III colorectal cancer patients with high risk of postoperative recurrence, we conducted a…”
    Get full text
    Journal Article
  4. 4

    Functional benefits of the double flap technique after proximal gastrectomy for gastric cancer by Saze, Zenichiro, Kase, Koji, Nakano, Hiroshi, Yamauchi, Naoto, Kaneta, Akinao, Watanabe, Yohei, Hanayama, Hiroyuki, Hayase, Suguru, Momma, Tomoyuki, Kono, Koji

    Published in BMC surgery (05-11-2021)
    “…Proximal gastrectomy is a widely performed procedure that has become more common with an increasing number of proximal gastric cancer cases. Several types of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration by Okamoto, Minoru, Hayase, Suguru, Miyakoshi, Masaaki, Murata, Tsubasa, Kimura, Shioko

    Published in PloS one (21-11-2013)
    “…Many tissues are thought to contain adult stem/progenitor cells that are responsible for repair of the tissue where they reside upon damage and/or…”
    Get full text
    Journal Article
  9. 9

    Immunotherapy for esophageal squamous cell carcinoma: a review by Mimura, Kosaku, Yamada, Leo, Ujiie, Daisuke, Hayase, Suguru, Tada, Takeshi, Hanayama, Hiroyuki, Min, Aung Kyi Thar, Shibata, Masahiko, Momma, Tomoyuki, Saze, Zenichiro, Ohki, Shinji, Kono, Koji

    Published in FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (01-01-2018)
    “…Cancer vaccines and immune checkpoint inhibitors (ICI) have recently been employed as immunotherapies for esophageal squamous cell carcinoma (ESCC). Cancer…”
    Get full text
    Journal Article
  10. 10

    Preoperative bacterial culture can predict severe pneumonia in patients receiving esophagectomy by Kaneta, Akinao, Sato, Takahiro, Nakano, Hiroshi, Matsumoto, Takuro, Tada, Takeshi, Watanabe, Yohei, Hanayama, Hiroyuki, Hayase, Suguru, Saze, Zenichiro, Kono, Koji

    “…Background:Postoperative pneumonia is one of the major complications after esophagectomy. The aim of this study was to determine whether bacterial cultures…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Current status of cancer immunotherapy for esophageal squamous cell carcinoma by Kono, Koji, Mimura, Kousaku, Yamada, Reo, Ujiie, Daisuke, Hayase, Suguru, Tada, Takeshi, Hanayama, Hiroyuki, Min, Aung Kyi Thar, Shibata, Masahiko, Momma, Tomoyuki, Saze, Zenichirou, Ohki, Shinji

    “…Background Immunotherapy has become a promising treatment strategy for cancer. Immune checkpoint blockade with anti-CTLA4 mAb and anti-PD-1 mAb has…”
    Get full text
    Journal Article
  15. 15

    Ectopic expression of MECA‐79 as a novel prognostic indicator in gastric cancer by Okayama, Hirokazu, Kumamoto, Kensuke, Saitou, Katsuharu, Hayase, Suguru, Kofunato, Yasuhide, Sato, Yu, Miyamoto, Kotaro, Nakamura, Izumi, Ohki, Shinji, Koyama, Yoshihisa, Ishii, Yoshimasa, Takenoshita, Seiichi

    Published in Cancer science (01-05-2011)
    “…The aim of this study was to clarify the clinical implications of a unique carbohydrate determinant, MECA‐79, in gastric cancer specimens and cells…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer by Hayase, Suguru, Yamada, Leo, Ujiie, Daisuke, Nirei, Azuma, Tada, Takeshi, Hanayama, Hiroyuki, Monma, Tomoyuki, Saze, Zenichiro, Ohki, Shinji, Kono, Koji

    “…Introduction Recently in Japan, Ramucirumab (RAM) became the first anti-angiogenic agent to be approved for second-line treatment of gastric cancer. In the…”
    Get full text
    Journal Article
  20. 20